相似文献
1
Intracranial stenting: SAMMPRIS.
Stroke. 2013 Jun;44(6 Suppl 1):S41-4. doi: 10.1161/STROKEAHA.111.000370.
2
Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
Neurosurgery. 2012 Dec;71(6):1103-10. doi: 10.1227/NEU.0b013e318271bcb8.
3
4
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):e51-60. doi: 10.1161/CIRCOUTCOMES.112.966911.
5
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.
J Neurointerv Surg. 2013 Nov;5(6):528-33. doi: 10.1136/neurintsurg-2012-010504. Epub 2012 Sep 12.
6
Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?
Stroke. 2012 Feb;43(2):580-4. doi: 10.1161/STROKEAHA.111.645507. Epub 2012 Jan 12.
7
Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
J Neuroimaging. 2012 Jan;22(1):1-13. doi: 10.1111/j.1552-6569.2011.00685.x.
8
Intervention for intracranial atherosclerosis after SAMMPRIS.
World Neurosurg. 2012 Nov;78(5):409-12. doi: 10.1016/j.wneu.2012.07.009. Epub 2012 Jul 20.
9
Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.
J Neurointerv Surg. 2009 Jul;1(1):35-9. doi: 10.1136/jnis.2009.000125. Epub 2009 Jul 3.
10
Internal carotid artery stenting for intracranial atherosclerosis.
Methodist Debakey Cardiovasc J. 2014 Oct-Dec;10(4):245-50. doi: 10.14797/mdcj-10-4-245.
引用本文的文献
1
Young stroke patient with patent foramen ovale and intracranial stenosis-a case report.
SAGE Open Med Case Rep. 2023 Jul 14;11:2050313X231187677. doi: 10.1177/2050313X231187677. eCollection 2023.
2
The Use of Pointwise Encoding Time Reduction With Radial Acquisition MRA to Assess Middle Cerebral Artery Stenosis Pre- and Post-stent Angioplasty: Comparison With 3D Time-of-Flight MRA and DSA.
Front Cardiovasc Med. 2021 Sep 9;8:739332. doi: 10.3389/fcvm.2021.739332. eCollection 2021.
3
Use of quantitative magnetic resonance angiography in patients with symptomatic intracranial arterial stenosis who undergo stenting: Presentation of three cases.
J Cerebrovasc Endovasc Neurosurg. 2021 Jun;23(2):136-144. doi: 10.7461/jcen.2021.E2020.10.005. Epub 2021 Jun 10.
4
China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
Interv Neuroradiol. 2015 Apr;21(2):196-204. doi: 10.1177/1591019915581778. Epub 2015 May 1.
本文引用的文献
1
Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz.
Stroke. 2012 Oct;43(10):2806-9. doi: 10.1161/strokeaha.112.661041.
2
Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).
Stroke. 2012 Oct;43(10):2682-8. doi: 10.1161/STROKEAHA.112.661173. Epub 2012 Sep 13.
3
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.
J Neurointerv Surg. 2013 Nov;5(6):528-33. doi: 10.1136/neurintsurg-2012-010504. Epub 2012 Sep 12.
4
Response from the SAMMPRIS trial principal investigators regarding inaccuracies in this editorial.
J Neurointerv Surg. 2016 Jun;8(e1):e5-6. doi: 10.1136/neurintsurg-2012-010496. Epub 2012 Sep 5.
5
Intracranial stenting for intracranial atherosclerotic disease: still much to learn.
J Neurointerv Surg. 2012 Mar;4(2):85-6. doi: 10.1136/neurintsurg-2012-010269.
6
Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz et al in the new England Journal of Medicine.
Stroke. 2012 Feb;43(2):616-20. doi: 10.1161/STROKEAHA.111.641563. Epub 2012 Jan 12.
7
Stenting versus aggressive medical therapy for intracranial arterial stenosis.
N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7.
8
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.
J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):357-68. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.001.
9
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis.
Stroke. 2009 Feb;40(2):505-9. doi: 10.1161/STROKEAHA.108.528281. Epub 2008 Dec 18.
10
The association of cigarette smoking with enhanced platelet inhibition by clopidogrel.
J Am Coll Cardiol. 2008 Aug 12;52(7):531-3. doi: 10.1016/j.jacc.2008.04.045.
Zotero 插件